| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0053 | 1 |